An increased KL-6 level in lung carcinoma patients has been associated with a poor prognosis [47] and downregulation of the MUC1 was claimed to inhibit the non-small cell lung carcinoma progression [48]. This evidence concerns the gene MUC1 and non-small cell lung carcinoma.